Who we are today

Bioretec Ltd. is a medical device company focusing on the development of strong, safe and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. Our products are used worldwide, and we continue to further develop materials and products for high load-bearing clinical applications.

We work under ISO 13485:2016 and FDA Part 820.
All our products hold CE certificate and most are also 510(k) cleared by the FDA.


Our mission is to introduce novel innovative, high quality bioabsorbable surgical devices, which improve patient healing, safety and cost-efficiency in clinical care. Ultimately the company goal is to improve the quality of life of people.


The Vision is to become a global player in the development and manufacturing of bioactive and bioabsorbable implants.


Humanity = All our products are developed for improving the quality of life of people. This is the basis for all company operations. All company actions and operations follow high ethical and moral values.

Quality = We are committed to providing its customers with high-quality and safe products and services according to the latest requirements and standards.

Innovation = We position ourself as the innovator and technological leader of the market. Our team seeks constantly for new technologies and solutions that fulfil unmet clinical needs. The entire company staff is engaged in the task of developing and implementing ways to reach the organization's goals.



Bioretec’s roots go back to the 1970's, when Professor Pertti Törmälä started research at the Tampere University of Technology, which resulted in the world's first bioabsorbable implants to be used in orthopedic surgery. In 1985, he established Bioscience Ltd. to manufacture and commercialize bioabsorbable orthopedic medical devices. This led to Bionx Implants Inc. that was successfully listed in NASDAQ New York in 1997. Bionx Implants Inc. was acquired by Conmed in 2003.

The spin-off company, BCI Bioabsorbable Concepts Oy was formed in 1998, and its name was changed to Bioretec Ltd. in 2003.

In 2019 Bioretec Ltd. acquired BRI.Tech GmbH located in Graz, Austria, a company that successfully developed and patented a magnesium based novel biocompatible and bioresorbable metal composition.

Management Team

Timo Lehtonen


Minna Ahlstedt-Soini

Production Director

Lauri Hokkanen

Director, Marketing and Sales

Mirja Katajamäki

Administration Manager

Kimmo Lähteenkorva

Chief Technology Officer

Mari Ruotsalainen

Director, QA & RA

Petrus Viitanen

IT Manager

Board of Directors

Mr. Tomi Numminen, Executive Chairman of the Board of Directors

Over 20 years of life science industry experience including positions of trust. CEO and CFO positions LAB Pharma, Vivoxid, Corbion, ReBio Technologies and Bioretec Ltd.

Prof. Pertti Törmälä, Member of the Board

Professor of Biomaterial technology. Founder of Bioretec Ltd. with over 1000 scientific publications, the developer of the first implanted orthopaedic bioabsorbable implant and founder of former Bionx Implants.

Mr. Heinz Moitzi, Member of the Board

One of the founders of BRI.Tech GmbH and Chief Operations Officer at international electronics corporation AT&S AG.

Mr. Michael Piccirillo, Member of the Board

Head of NuVasive Clinical Professional Development Programme and Partner at Valugen GmbH. Former Executive Director of AOSpine and AOTrauma.

Mr. Hans Rosén, Member of the Board

Managing Director at Theradex Oncology. Life science industry veteran, with CEO and Director positions at Abigo Medical AB, Vivolux Inc., Artimplant AB, Diffchamb, aB, Civenta AB and Chromogenix AB.